C07C 333/02
Monothiocarbamic acids
Official title: Monothiocarbamic acids; Derivatives thereof
C07C333/02 (Monothiocarbamic acids) appears on 303 US grants and 202 published applications in this corpus.
Search patents in C07C- Granted patents
- 303
- Published applications
- 202
- Assignees
- 184
- Inventors
- 857
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 10 | 0 |
| 1977 | 6 | 0 |
| 1978 | 7 | 0 |
| 1979 | 3 | 0 |
| 1980 | 1 | 0 |
| 1981 | 3 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 3 | 0 |
| 1985 | 1 | 0 |
| 1986 | 3 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 5 | 0 |
| 1991 | 4 | 0 |
| 1992 | 13 | 0 |
| 1993 | 11 | 0 |
| 1994 | 7 | 0 |
| 1995 | 4 | 0 |
| 1996 | 8 | 0 |
| 1997 | 5 | 0 |
| 1998 | 20 | 0 |
| 1999 | 9 | 0 |
| 2000 | 5 | 0 |
| 2001 | 12 | 2 |
| 2002 | 12 | 8 |
| 2003 | 9 | 4 |
| 2004 | 10 | 12 |
| 2005 | 4 | 7 |
| 2006 | 1 | 6 |
| 2007 | 6 | 7 |
| 2008 | 2 | 4 |
| 2009 | 7 | 7 |
| 2010 | 4 | 8 |
| 2011 | 5 | 3 |
| 2012 | 6 | 6 |
| 2013 | 3 | 11 |
| 2014 | 5 | 2 |
| 2015 | 9 | 11 |
| 2016 | 5 | 9 |
| 2017 | 11 | 13 |
| 2018 | 8 | 9 |
| 2019 | 8 | 6 |
| 2020 | 7 | 6 |
| 2021 | 8 | 10 |
| 2022 | 3 | 7 |
| 2023 | 8 | 15 |
| 2024 | 8 | 11 |
| 2025 | 4 | 10 |
| 2026 | 8 | 8 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C07C 333/04Having nitrogen atoms of thiocarbamic groups bound to hydrogen atoms or to179
- C07C 333/08Having nitrogen atoms of thiocarbamic groups bound to carbon atoms of six-membered77
- C07C 333/10Having nitrogen atoms of thiocarbamic groups being part of any of the23
- C07C 333/06Having nitrogen atoms of thiocarbamic groups bound to carbon atoms of rings17
- C07C 333/12Having nitrogen atoms of thiocarbamic groups bound to other hetero atoms13
Recent patents
- Ionizable cationic lipids for RNA delivery1 Sep 2026US 12,723,023 B2Arcturus Therapeutics, Inc.
- Ionizable cationic lipid for RNA delivery26 May 2026US 12,637,422 B2Arcturus Therapeutics, Inc.
- Dimers for use in synthesis of peptidomimetics12 May 2026US 12,624,002 B2The Feinstein Institutes for Medical Research
- Rapidly metabolized lipid compound5 May 2026US 12,617,752 B2Beijing Jitai Life Sciences Ltd
- Compounds and methods for treating alcohol disorder28 Apr 2026US 12,612,365 B2Sophrosyne Pharmaceuticals Limited
- Lipid nanoparticle for targeted delivery of therapeutic payloads24 Sep 2026US 2026/0285801 A1Trustees of Tufts College
- Rapidly metabolized lipid compound9 Jul 2026US 2026/0193167 A1Beijing Jitai Life Sciences Ltd
- Additive mixtures for rheology modification of polymers2 Jul 2026US 2026/0184859 A1BASF SE
- Bromodomain inhibitors for cancer therapy18 Jun 2026US 2026/0167646 A1University of Tennessee Research Foundation
- Bis-ligand chalcopyrite collector and preparation method and application thereof28 May 2026US 2026/0145179 A1Qingdao University of Science and Technology
Most cited
By later US patents
- Drug composition containing nucleic acid copolymer208US 5,705,188 ANippon Shinyaku Co., Ltd. · 1998
- 9-substituted minocycline compounds83US 6,846,939 B2Paratek Pharmaceuticals, Inc. · 2005
- 7-and 9-carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds79US 6,818,634 B2Paratek Pharmaceuticals, Inc. · 2004
- Inhibitors of IMPDH enzyme technical field of the invention73US 6,653,309 B1Vertex Pharmaceuticals Incorporated · 2003
- N-acylsulfonamides, novel mixtures of herbicides and antidotes, and their use60US 6,235,680 B1Hoechst Schering AgrEvo GmbH · 2001